Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, October 01, 2018 1:04:32 PM
The offering has a price above the current stock price at $3.1445 per share which is not the norm for offerings, usually they are lower than the current stock price IMHO.
In the past on various stocks, it seemed to me that the chart price very quickly goes to the offering price after it is known.
Perhaps people glossed over that and saw the word offering only. Perhaps not too many people are following the news to react to the (higher than the current chart) offering price.
But in this case the offering price is higher than the chart (not lower) and doesn't undercut people who just bought. This to me seems bullish. Thoughts?
offering announcement
https://ih.advfn.com/p.php?pid=nmona&article=78366704
Recent ACHV News
- Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 08:01:21 PM
- Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 • GlobeNewswire Inc. • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:49:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:43:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:41:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:16:29 PM
- Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission • GlobeNewswire Inc. • 02/29/2024 01:01:00 PM
- Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/27/2024 08:32:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 07:07:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:22:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:20:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:09:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:07:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:05:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:01:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 11:58:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 11:54:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:04:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:08:29 PM
- Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 09:00:00 PM
- Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 • GlobeNewswire Inc. • 10/26/2023 12:00:00 PM
- Achieve Life Sciences Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 10/03/2023 12:00:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM